Randomized trialMedical2026
Dose-Dependent Effects of Cannabis Edibles on Simulated Driving Performance: A Randomized Clinical Trial.
Le Foll B.; Matheson J.; Antwi P.; Wright M.; Zaweel A.; Hasan O.; Kloiber S.; Hassan A.; Sproule B.; Wickens C. et al. · JAMA network open · 2026
Research summary
**Background & Methods**
This randomized, double-blind, placebo-controlled crossover trial enrolled 40 healthy adult cannabis users (mean age 30.4 years) at a Canadian academic hospital to evaluate dose-dependent effects of THC edibles on simulated driving performance. Participants received soft-chew gummies containing 0, 2, 10, or 20 mg of delta-9-tetrahydrocannabinol (THC), with primary outcome measures of standard deviation of lateral position (SDLP) assessed at 2 and 5 hours post-exposure.
**Key Findings**
• THC dose-dependently impaired simulated driving performance: SDLP significantly increased at 20 mg (3.3 cm; P<.001) and 10 mg (2.0 cm; P<.001) relative to placebo, but not at 2 mg (0.7 cm; P=.16).
• Secondary driving measures were adversely affected by higher THC doses: reaction time increased significantly at 20 mg (0.034 seconds; P<.001) and standard deviation of speed increased at 20 mg (0.469 km/h; P=.004) compared with placebo.
• Peak whole-blood THC concentrations (3.4 ng/mL at 20 mg and 1.6 ng/mL at 10 mg) were at or below commonly used per se legal thresholds for driving impairment (2-5 ng/mL), yet significant performance deficits were observed.
• Self-reported measures showed dose-dependent decreases: willingness to drive and perceived driving ability were significantly reduced at 20 mg (P<.001), suggesting some user awareness of impairment.
**Dosage & Administration**
THC edibles administered as soft-chew gummies in doses of 0, 2, 10, and 20 mg. Assessment occurred at 2 and 5 hours post-ingestion.
**Safety & Adverse Effects**
Not reported.
**Evidence Quality**
This is a well-designed RCT with appropriate blinding and crossover methodology, representing moderate-to-high quality evidence. Limitations include small sample size (40 participants), single-site recruitment limiting generalizability, and use of simulated driving rather than real-world driving assessment. The population was restricted to regular cannabis users aged 19-45, which may not represent all drivers. The finding that impairment occurs below legal per se thresholds has important implications for cannabis-impaired driving legislation, though additional research in naturalistic driving settings is warranted.
Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.
Study type
Randomized trial
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed
More recent cannabis research
This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.